secwatch / observer
8-K filed July 31, 2024, 7:59 PM ET ticker XRAY CIK 0000818479
earnings confidence high sentiment negative materiality 0.75

DENTSPLY SIRONA Inc. (XRAY): restructuring charge — Dentsply Sirona Q2 net loss $4M, lowers FY24 outlook, begins restructuring

DENTSPLY SIRONA Inc.

2024-Q2 EPS reported $0.07 revenue$1,937,000,000

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Andreas G. Frank

Executive Vice President, Chief Business Officer
XRAY · DENTSPLY SIRONA Inc.
Effective
2024-10-01
Filed
July 31, 2024, 7:59 PM ET
On July 31, 2024, as part of the restructuring plan described in Item 2.05 herein, the Company eliminated the position of Executive Vice President, Chief Business Officer which is currently held by Mr. Andreas G. Frank, effective October 1, 2024, or such other date as mutually agreed to between the parties (the “Termination Date”).
Departed

Richard M. Wagner

Vice President, Chief Accounting Officer
XRAY · DENTSPLY SIRONA Inc.
Effective
2024-08-16
Successor
Glenn G. Coleman
Filed
July 31, 2024, 7:59 PM ET
Additionally, on July 25, 2024, Richard M. Wagner informed the Company of his decision to resign as Vice President, Chief Accounting Officer of the Company effective August 16, 2024, to pursue another opportunity.
Role change (interim)

Glenn G. Coleman

interim principal accounting officer
XRAY · DENTSPLY SIRONA Inc.
Effective
2024-08-16
Filed
July 31, 2024, 7:59 PM ET
In connection with Mr. Wagner’s resignation, Glenn G. Coleman, Executive Vice President, Chief Financial Officer, will assume the responsibilities of principal accounting officer on an interim basis, effective August 16, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Andreas G. Frank departed as Executive Vice President, Chief Business Officer at DENTSPLY SIRONA Inc..

Action
departed
Role
Executive Vice President, Chief Business Officer
Exact text from the filing
On July 31, 2024, as part of the restructuring plan described in Item 2.05 herein, the Company eliminated the position of Executive Vice President, Chief Business Officer which is currently held by Mr. Andreas G. Frank, effective October 1, 2024, or such other date as mutually agreed to between the parties (the “Termination Date”).
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Richard M. Wagner resigned as Vice President, Chief Accounting Officer at DENTSPLY SIRONA Inc..

Action
resigned
Role
Vice President, Chief Accounting Officer
Exact text from the filing
Additionally, on July 25, 2024, Richard M. Wagner informed the Company of his decision to resign as Vice President, Chief Accounting Officer of the Company effective August 16, 2024, to pursue another opportunity.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Glenn G. Coleman changed role as interim principal accounting officer at DENTSPLY SIRONA Inc..

Action
assumed
Role
interim principal accounting officer
Exact text from the filing
In connection with Mr. Wagner’s resignation, Glenn G. Coleman, Executive Vice President, Chief Financial Officer, will assume the responsibilities of principal accounting officer on an interim basis, effective August 16, 2024.
View on SEC.gov
Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.98

DENTSPLY SIRONA Inc. announced a restructuring with charges of between $40 million and $50 million in non-recurring restructuring charges affecting global workforce (net reduction in the Company's global workforce of approximately 2% to 4%).

Type
restructuring
Charge
between $40 million and $50 million in non-recurring restructuring charges
Affected area
global workforce
Headcount
net reduction in the Company's global workforce of approximately 2% to 4%
Exact text from the filing
On July 29, 2024, the Board of Directors of the Company approved a plan to restructure the Company’s business to improve operational performance and drive shareholder value creation. The restructuring plan anticipates a net reduction in the Company’s global workforce of approximately 2% to 4%. The proposed changes are subject to co-determination processes with employee representative groups in countries where required. The Company expects to incur between $40 million and $50 million in non-recurring restructuring charges under the plan, primarily related to employee transition, severance payments and employee benefits, which are expected to be expensed and paid in cash in 2024 and 2025.
View on SEC.gov

7 restructurings & charges filed in the last 30 days. Browse all restructurings & charges →

DENTSPLY SIRONA Inc. filing history →

Source: SEC EDGAR
accession 0000818479-24-000070
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.